2021
DOI: 10.3390/cells10092303
|View full text |Cite
|
Sign up to set email alerts
|

Perspective: Why and How Ubiquitously Distributed, Vascular-Associated, Pluripotent Stem Cells in the Adult Body (vaPS Cells) Are the Next Generation of Medicine

Abstract: A certain cell type can be isolated from different organs in the adult body that can differentiate into ectoderm, mesoderm, and endoderm, providing significant support for the existence of a certain type of small, vascular-associated, pluripotent stem cell ubiquitously distributed in all organs in the adult body (vaPS cells). These vaPS cells fundamentally differ from embryonic stem cells and induced pluripotent stem cells in that the latter possess the necessary genetic guidance that makes them intrinsically … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
44
0
5

Year Published

2021
2021
2024
2024

Publication Types

Select...
3
2

Relationship

4
1

Authors

Journals

citations
Cited by 11 publications
(50 citation statements)
references
References 145 publications
(232 reference statements)
1
44
0
5
Order By: Relevance
“…This is based not only on ethical concerns and the risk of development of teratomas (i.e. tumors derived from embryonic stem cells), but also on the allogeneic nature of embryonic cells [ 1 , 2 ]. Even for so-called induced pluripotent stem cells (iPS cells), the development of which was honored with a Nobel Prize for Medicine in 2012, clinical applications are missing, not only for the complexity of the procedure, but particularly based on the risk of malignant transformation of these cells (i.e.…”
Section: Introductionmentioning
confidence: 99%
See 4 more Smart Citations
“…This is based not only on ethical concerns and the risk of development of teratomas (i.e. tumors derived from embryonic stem cells), but also on the allogeneic nature of embryonic cells [ 1 , 2 ]. Even for so-called induced pluripotent stem cells (iPS cells), the development of which was honored with a Nobel Prize for Medicine in 2012, clinical applications are missing, not only for the complexity of the procedure, but particularly based on the risk of malignant transformation of these cells (i.e.…”
Section: Introductionmentioning
confidence: 99%
“…Even for so-called induced pluripotent stem cells (iPS cells), the development of which was honored with a Nobel Prize for Medicine in 2012, clinical applications are missing, not only for the complexity of the procedure, but particularly based on the risk of malignant transformation of these cells (i.e. the development of cancer) [ 1 , 2 ]. For completeness, the transplantation of stem cells from the bone marrow in leukemia [ 3 ] should be mentioned, but this will not be discussed here further.…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations